PRISM MEDICO AND PHARMACY LTD.

Prism Medico and Pharmacy Ltd has filed its Annual Report for the Financial Year 2025-2026, as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report includes the company's audited financial statements, Board's Report, and Auditor's Report. The 24th Annual General Meeting (AGM) is scheduled for September 19, 2026, to be held via Video Conferencing. Key agenda items include the adoption of financial statements, re-appointment of a director retiring by rotation, re-appointment of statutory auditors M/s. Garg Mendiratta & Associates, and appointment of M/s. SDK & Associates as secretarial auditors for five years.

Prism Medico and Pharmacy Ltd has announced the record date for its 24th Annual General Meeting (AGM), scheduled for September 19, 2026. The AGM will be conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The company's Register of Members and Share Transfer Books will remain closed from September 13 to September 19, 2026, inclusive. E-voting will commence on September 16 and conclude on September 18, 2026. This announcement sets the crucial dates for shareholder participation in the company's annual governance.

Prism Medico and Pharmacy Ltd has filed its Annual Report for the Financial Year 2025-2026, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report includes the audited financial statements, Board's Report, and Auditor's Report. The company has also announced its 24th Annual General Meeting (AGM) to be held on September 19, 2026, through Video Conferencing. Key agenda items include the adoption of financial statements, re-appointment of a director retiring by rotation, re-appointment of statutory auditors M/s. Garg Mendiratta & Associates, and appointment of M/s. SDK & Associates as secretarial auditors for five years.

Prism Medico and Pharmacy Ltd has announced its 24th Annual General Meeting (AGM) will be held on September 19, 2026, commencing at 12:30 PM IST. The meeting will be conducted virtually through Video Conferencing (VC) and Other Audio Visual Means (OAVM). Key agenda items include the adoption of audited financial statements for FY26, re-appointment of a director retiring by rotation, re-appointment of M/s. Garg Mendiratta and Associates as statutory auditors, and appointment of M/s. SDK & Associates as secretarial auditors for five years. Additionally, the company will seek approval for a variation in the objects and utilization of proceeds from a Preferential Issue.

Prism Medico and Pharmacy Ltd's Board of Directors met on August 24, 2026, approving the Director's Report for the Financial Year ended March 31, 2026. The board also approved the notice for the 24th Annual General Meeting (AGM) scheduled for September 19, 2026, at 12:30 PM via VC/OAVM. The register of members and share transfer books will be closed from September 13 to September 19, 2026, for the AGM. A cut-off date of September 12, 2026, was fixed for e-voting entitlement. The board recommended the re-appointment of Garg Mendiratta and Associates as Statutory Auditors and SDK & Associates as Secretarial Auditors for five years. Investment of company funds and variation in objects of a Preferential Issue were also considered.

Prism Medico and Pharmacy Ltd has announced a Board of Directors meeting scheduled for August 24, 2026. The meeting agenda includes the consideration and approval of the Director's Report for the financial year ended March 31, 2026. Additionally, the board will fix the date for the 24th Annual General Meeting (AGM), approve its notice, and determine the closure of the Register of Members and Share Transfer Books for the AGM. The appointment of a scrutinizer for e-voting and poll processes at the AGM will also be considered. Furthermore, the board will discuss the re-appointment of M/s. Garg Mendiratta and Associates as statutory auditors and M/s. SDK & Associates as secretarial auditors for five financial years.

Prism Medico and Pharmacy Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and a Limited Review Report was issued by Garg Mendiratta & Associates. Mr. Davender Singh, Director, has been authorized to sign the financial statements.

Prism Medico and Pharmacy Ltd has announced that its Board of Directors will convene on August 12, 2026, at its registered office in Himachal Pradesh. The primary agenda item for this meeting is to consider, approve, and take on record the Unaudited Standalone Financial Results for the quarter ended June 30, 2026, along with the accompanying Limited Review Report. The meeting is scheduled to commence at 01:30 P.M. Additionally, the board will discuss any other routine business matters. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Prism Medico and Pharmacy Limited has announced that its official website has been updated and is now functional. This update is in compliance with Regulation 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided its website address as https://www.prismmedico.in for public access and record-keeping purposes.

Prism Medico and Pharmacy Ltd has filed its investor complaint statement for the quarter ended June 30, 2026. The company reported zero pending complaints at the beginning of the quarter, zero received during the quarter, zero disposed of, and zero remaining unresolved at the end of the quarter. This indicates a period of no investor grievances for the company.